Evidence map›Paper›PMID 30054724›Full record

ArticleHuman genetics2018

Whole-exome sequencing identifies rare genetic variations in German families with pulmonary sarcoidosis.

Amit Kishore, Britt-Sabina Petersen, Marcel Nutsua, Joachim Müller-Quernheim, Andre Franke, Annegret Fischer, Stefan Schreiber, Martin Petrek

Abstract read
PubMed Publisher
In one paragraph

Article in Human genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Amit KishoreInstitute of Clinical Molecular Biology, Kiel University, Kiel, Germany.
Britt-Sabina PetersenInstitute of Clinical Molecular Biology, Kiel University, Kiel, Germany.
Marcel NutsuaInstitute of Clinical Molecular Biology, Kiel University, Kiel, Germany.
Joachim Müller-QuernheimDepartment of Pneumology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Andre FrankeInstitute of Clinical Molecular Biology, Kiel University, Kiel, Germany.
Annegret FischerInstitute of Clinical Molecular Biology, Kiel University, Kiel, Germany.
Stefan SchreiberInstitute of Clinical Molecular Biology, Kiel University, Kiel, Germany. s.schreiber@mucosa.de.
Martin PetrekDepartment of Pathological Physiology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic. martin.petrek@fnol.cz.
Kiel University · DEPalacký University Olomouc · CZUniversity Medical Center Freiburg · DEUniversity of Lübeck · DE

Funding

Deutsche Forschungsgemeinschaft EXC 306Deutsche Forschungsgemeinschaft FI 1935/1-1NV18-05-00134 NV18-05-00134Univerzita Palackého v Olomouci IGA_LF_2018_015
6 · The paper itself

Abstract

Genome-wide and candidate gene studies for pulmonary sarcoidosis have highlighted several candidate variants among different populations. However, the genetic basis of functional rare variants in sarcoidosis still needs to be explored. To identify functional rare variants in sarcoidosis, we sequenced exomes of 22 sarcoidosis cases from six families. Variants were prioritized using linkage and high-penetrance approaches, and filtered to identify novel and rare variants. Functional networking and pathway analysis of identified variants was performed using gene ontology based gene-phenotype, gene-gene, and protein-protein interactions. The linkage (n = 1007-7640) and high-penetrance (n = 11,432) prioritized variants were filtered to select variants with (a) reported allele frequency < 5% in databases (1.2-3.4%) or (b) novel (0.7-2.3%). Further selection based on functional properties and validation revealed a panel of 40 functional rare variants (33 from linkage region, 6 highly penetrant and 1 shared by both approaches). Functional network analysis implicated these gene variants in immune responses, such as regulation of pro-inflammatory cytokines including production of IFN-γ and anti-inflammatory cytokine IL-10, leukocyte proliferation, bacterial defence, and vesicle-mediated transport. The KEGG pathway analysis indicated inflammatory bowel disease as most relevant. This study highlights the subsets of functional rare gene variants involved in pulmonary sarcoidosis, such as, regulations of calcium ions, G-protein-coupled receptor, and immune system including retinoic acid binding. The implicated mechanisms in etiopathogenesis of familial sarcoidosis thus include Wnt signalling, inflammation mediated by chemokine and cytokine signalling and cadherin signalling pathways.

Indexed as

ExomeGene Regulatory NetworksGenetic MarkersGenetic Predisposition to DiseaseGenetic VariationFemaleGenome-Wide Association StudyGenotypeHumansMalePedigreePhenotypeSarcoidosis, PulmonarySequence Analysis, DNAGenetic Markers

Identifiers

PMID30054724
OpenAlexW2884880157

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.